Search research articles
Contact Us
Filters
Showing results (711-720 of 716) with videos related to
Page
of 72
Sort By:
You have reached the last page of results.
This site can display upto 716 results.
Science Translational Medicine
|
August 27, 2010
Recommendations for biomarker identification and qualification in clinical proteomics
Harald Mischak, Günter Allmaier, Rolf Apweiler, et al.
Nature Genetics
|
December 28, 2010
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
, , Kaixin Zhou, et al.
Nature Genetics
|
August 9, 2016
Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
Kaixin Zhou, Sook Wah Yee, Eric L Seiser, et al.
The New England Journal of Medicine
|
March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events
, Rury R Holman, Steven M Haffner, et al.
The New England Journal of Medicine
|
March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events
, John J McMurray, Rury R Holman, et al.
Cardiovascular Diabetology
|
May 7, 2026
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum
Oliver Schnell, Arnav Agarwal, Michel Azizi, et al.
Page
of 72
Search research articles
Search
Showing results (711-720 of 716) with videos related to
Sort By:
Page
of 72
You have reached the last page of results.
This site can display upto 716 results.
Science Translational Medicine
|
August 27, 2010
Recommendations for biomarker identification and qualification in clinical proteomics
Harald Mischak, Günter Allmaier, Rolf Apweiler, et al.
Nature Genetics
|
December 28, 2010
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
, , Kaixin Zhou, et al.
Nature Genetics
|
August 9, 2016
Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
Kaixin Zhou, Sook Wah Yee, Eric L Seiser, et al.
The New England Journal of Medicine
|
March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events
, Rury R Holman, Steven M Haffner, et al.
The New England Journal of Medicine
|
March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events
, John J McMurray, Rury R Holman, et al.
Cardiovascular Diabetology
|
May 7, 2026
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum
Oliver Schnell, Arnav Agarwal, Michel Azizi, et al.
Page
of 72